AIMC Topic: Hypoglycemic Agents

Clear Filters Showing 1 to 10 of 140 articles

Machine learning driven diabetes care using predictive-prescriptive analytics for personalized medication prescription.

Scientific reports
The increasing prevalence of type 2 diabetes (T2D) is a significant health concern worldwide. Effective and personalized treatment strategies are essential for improving patient outcomes and reducing healthcare costs. Machine learning (ML) has the po...

BertADP: a fine-tuned protein language model for anti-diabetic peptide prediction.

BMC biology
BACKGROUND: Diabetes is a global metabolic disease that urgently calls for the development of new and effective therapeutic agents. Anti-diabetic peptides (ADPs) have emerged as a research hotspot due to their therapeutic potential and natural safety...

Research Gaps, Challenges, and Opportunities in Automated Insulin Delivery Systems.

Journal of diabetes science and technology
BACKGROUND: Since the discovery of the life-saving hormone insulin in 1921 by Dr Frederick Banting in 1921, there have been many critical discoveries and technical breakthroughs that have enabled people living with type 1 diabetes (T1D) to live longe...

In-silico guided identification and studies of potential FFAR4 agonists for type 2 diabetes mellitus therapy.

Expert opinion on drug discovery
BACKGROUND: The activation of free fatty acid receptor 4 (FFAR4) enhances insulin sensitivity and glucose uptake while mitigating inflammation. It is a promising therapeutic approach for managing type 2 diabetes mellitus (T2DM).

Chemical Properties-Based Deep Learning Models for Recommending Rational Daily Diet Combinations to Diabetics Through Large-Scale Virtual Screening of α-Glucosidase Dietary-Derived Inhibitors and Verified In Vitro.

Journal of agricultural and food chemistry
The lack of suitable chemical research methodologies has hindered the discovery of rational daily diet combinations from large-scale dietary-derived compounds. Three deep learning models based on chemical properties for α-glucosidase inhibitors (AGIs...

Enhancing Antidiabetic Drug Selection Using Transformers: Machine-Learning Model Development.

JMIR medical informatics
BACKGROUND: Diabetes affects millions worldwide. Primary care physicians provide a significant portion of care, and they often struggle with selecting appropriate medications.

Machine learning applications to classify and monitor medication adherence in patients with type 2 diabetes in Ethiopia.

Frontiers in endocrinology
BACKGROUND: Medication adherence plays a crucial role in determining the health outcomes of patients, particularly those with chronic conditions like type 2 diabetes. Despite its significance, there is limited evidence regarding the use of machine le...

SERPINA3: A Novel Therapeutic Target for Diabetes-Related Cognitive Impairment Identified Through Integrated Machine Learning and Molecular Docking Analysis.

International journal of molecular sciences
Diabetes-related cognitive impairment (DCI) is a severe complication of type 2 diabetes mellitus (T2DM), with limited understanding of its molecular mechanisms hindering effective therapeutic development. This study identified SERPINA3 as a potential...

Food-derived DPP4 inhibitors: Drug discovery based on high-throughput virtual screening and deep learning.

Food chemistry
Dipeptidyl peptidase-4 (DPP-4) is a critical target for the treatment of type 2 diabetes. This study outlines the development of six compounds derived from food sources and modified to create promising candidates for the treatment of diabetes. These ...